(RTTNews) - The Malaysia stock market turned lower again on Wednesday, one day after ending the two-day losing streak in which it had slumped more than a dozen points or 0.6 percent. The Kuala Lumpur Composite Index now sits just above the 1,745-point plateau although it may boun
(RTTNews) - The Malaysia stock market turned lower again on Wednesday, one day after ending the two-day losing streak in which it had slumped more than a dozen points or 0.6 percent. The Kuala Lumpur Composite Index now sits just above the 1,745-point plateau although it may boun
Earnings Call Insights: Journey Medical (DERM) Q1 2026 Management View "We made solid progress in the first quarter of 2026, marking a strong start to what we believe will be a breakout year for Emrosi and Journey Medical." (Founder, President, CEO & Director Claude Maraoui) "We delivered Emrosi revenues of $6.3 million in Q1... as prescription volumes continue to grow and payer reimbursement impr...
Earnings Call Insights: Journey Medical (DERM) Q1 2026 Management View "We made solid progress in the first quarter of 2026, marking a strong start to what we believe will be a breakout year for Emrosi and Journey Medical." (Founder, President, CEO & Director Claude Maraoui) "We delivered Emrosi revenues of $6.3 million in Q1... as prescription volumes continue to grow and payer reimbursement improves." (Founder, President, CEO & Director Maraoui) "In April, we announced that we entered into an agreement with the third of the 3 largest PBM-owned or affiliated group purchasing organizations in the United States... With the big 3 contracts in place for Emrosi, over 169 million of the 192 million commercial lives in the nation now have access to Emrosi." (Founder, President, CEO & Director Maraoui) "Operationally, we plan to add up to 5 new sales professionals to our commercial team this year... and, importantly, the establishment of Emrosi as standard of care in the treatment of rosacea." (Founder, President, CEO & Director Maraoui) "Total revenue for the quarter was $16 million... Emrosi... generated $6.3 million in net revenue... We reported a GAAP net loss of $2.2 million or $0.08 per share... On a non-GAAP basis, adjusted EBITDA was positive $600,000... We ended the quarter with $27.2 million in cash." (CFO & Corporate Controller Joseph Benesch) Outlook "While we plan to offer detailed financial guidance later this year, we are confident that the business will not only deliver positive adjusted EBITDA, but will also generate positive EBITDA for the remainder of this year and for the foreseeable future." (Founder, President, CEO & Director Maraoui) "We believe the additional resources will increase our productivity... the potential launch of up to 2 new niche dermatology products later this year." (Founder, President, CEO & Director Maraoui) "We're not ready to announce anything yet, but we're in very deep discussions and far along in discussions with some of the n...
Earnings Call Insights: Cytosorbents (CTSO) Q1 2026 Management View CEO Phillip Chan said Cytosorbents is “positioning the company for future growth” while “strengthen[ing] and streamline[ing] the business,” emphasizing a “highly scalable razor blade type recurring revenue model” and reiterating that “CytoSorb is not currently approved or cleared in the United States or Canada,” while “DrugSorb-AT...
Earnings Call Insights: Cytosorbents (CTSO) Q1 2026 Management View CEO Phillip Chan said Cytosorbents is “positioning the company for future growth” while “strengthen[ing] and streamline[ing] the business,” emphasizing a “highly scalable razor blade type recurring revenue model” and reiterating that “CytoSorb is not currently approved or cleared in the United States or Canada,” while “DrugSorb-ATR remains an investigational device.” (CEO & Director Phillip Chan) Chan reported Q1 revenue “grew 2% year-over-year to $8.9 million” despite “temporary external headwinds,” highlighting “continued deceleration in our Direct International business outside Germany, which grew 13% year-over-year,” while noting Germany “sales declined” but “productivity has improved and customer engagement has strengthened under new leadership,” with plans to “selectively rebuild portions of the sales force.” (CEO & Director Chan) Chan said distributor sales were “negatively impacted by geopolitical disruption in the Middle East…surrounding the U.S. Iran war,” which “delayed approximately $0.5 million in expected orders,” and added gross margin “remained strong at 69%,” with the decline “intentional as we strategically slowed production levels to reduce inventory and improve working capital efficiency.” (CEO & Director Chan) CFO Peter Mariani stated, “operating expenses were $9.2 million…compared to $10.1 million a year ago,” and said costs reflect “initial benefits of our strategic headcount and cost reduction program implemented in the fourth quarter of last year,” adding, “we expect the costs will continue to decrease sequentially.” (Chief Financial Officer Peter Mariani) Chief Medical Officer Efthymios Deliargyris said FDA has requested “additional mechanistic data…together with the real world evidence” for DrugSorb-ATR’s new de novo submission, and characterized mechanistic data as “non-clinical outcome data…to support the mechanism of action of the device.” (Chief Medical Officer Efthymi...
SAN FRANCISCO, May 13, 2026--Origin Lab, the technology platform turning licensed game worlds into structured training data for world models and multimodal AI, today announced an $8M seed round led by Lightspeed Venture Partners. The financing will accelerate Origin Lab’s software, capture, enrichment, QA, search, and delivery systems, while expanding its applied research work in world understandi...
SAN FRANCISCO, May 13, 2026--Origin Lab, the technology platform turning licensed game worlds into structured training data for world models and multimodal AI, today announced an $8M seed round led by Lightspeed Venture Partners. The financing will accelerate Origin Lab’s software, capture, enrichment, QA, search, and delivery systems, while expanding its applied research work in world understanding, dataset intelligence, and interactive simulation. SV Angel, Eniac, Seven Stars, FPV and angels f
Chinese memory module manufacturers are accelerating the release of consumer and enterprise storage products powered by domestic DDR5 chips, as breakthroughs by ChangXin Memory Technologies (CXMT), the nation’s leading memory chipmaker, filter through the supply chain. Powev, one of China’s major memory module vendors, recently said its Sinker-branded DDR5 server memories had entered mass producti...
Chinese memory module manufacturers are accelerating the release of consumer and enterprise storage products powered by domestic DDR5 chips, as breakthroughs by ChangXin Memory Technologies (CXMT), the nation’s leading memory chipmaker, filter through the supply chain. Powev, one of China’s major memory module vendors, recently said its Sinker-branded DDR5 server memories had entered mass production and delivery. The 64GB DDR5-5600 RDIMM product passed testing by multiple major customers and was...
Péter Magyar says his government has summoned Russian ambassador over drone attack near Hungary’s border to ask when Vladimir Putin plans ‘to finally end this bloody war’. What we know on day 1,541 Hungarian prime minister Péter Magyar says his new government has summoned the Russian ambassador over a massive drone attack near Hungary’s border in a significant shift from his predecessor’s friendly...
Péter Magyar says his government has summoned Russian ambassador over drone attack near Hungary’s border to ask when Vladimir Putin plans ‘to finally end this bloody war’. What we know on day 1,541 Hungarian prime minister Péter Magyar says his new government has summoned the Russian ambassador over a massive drone attack near Hungary’s border in a significant shift from his predecessor’s friendly relations with Moscow . “The Hungarian government strongly condemns the Russian attack on Transcarpathia,” Magyar told journalists. He said the Hungarian foreign minister will speak with the Russian ambassador Thursday morning. Under the outgoing government voted out of office this month, Hungary blocked aid for Ukraine and tried to slow its efforts to join the EU. Magyar said his foreign minister will ask “when Russia and Vladimir Putin plan to finally end this bloody war” . Ukrainian president Volodymyr Zelenskyy replied on X: “Thank you for your compassion and strong position!” Russia fired at least 800 drones in a massive daytime barrage on about 20 regions of Ukraine on Wednesday , Peter Beaumont writes . The strikes came as Kyiv and Moscow traded long-range attacks after a brief ceasefire. Ukrainian monitors detected at least eight salvoes of Russian drones, including some entering from Belarus , with the apparent target being Kyiv’s critical infrastructure. Poland scrambled fighter jets as a preventive measure due to the Russian airstrikes on Ukraine , the Polish army said. The governors of two Russian regions bordering Ukraine, both frequent targets of Ukrainian attacks, have stepped down and their replacements met with President Vladimir Putin , the Kremlin said on Wednesday. Vyacheslav Gladkov, governor of the Belgorod Region, and Alexander Bogomaz, governor of the Bryansk Region, both stepped down at their own request, the Kremlin said. Russian media said Alexander Shuvaev, a highly decorated veteran , is the new governor of Belgorod, and Yegor Kovalchuk, a bank...
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ("Oracle" or the "Company") announces that John Lee, a director of the Company, acquired 3,280,000 Units at $0.05 per unit (the "Units") with respect to the private placement which closed on April 6, 2026 for consideration of $164,000 (the "Private Placement"). Immediately befo...
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ("Oracle" or the "Company") announces that John Lee, a director of the Company, acquired 3,280,000 Units at $0.05 per unit (the "Units") with respect to the private placement which closed on April 6, 2026 for consideration of $164,000 (the "Private Placement"). Immediately before the Private Placement, Mr. Lee directly or indirectly held an aggregate of 9,837,640 Common...
Citadel has moved some of its researchers out of Hong Kong due to data security concerns, the Financial Times reported , citing people familiar with the matter. The US hedge fund told members of its Hong Kong-based global quantitative strategies team that they had to either relocate or leave the firm, the people told the FT. Some researchers relocated to Singapore or Miami while others quit, the p...
Citadel has moved some of its researchers out of Hong Kong due to data security concerns, the Financial Times reported , citing people familiar with the matter. The US hedge fund told members of its Hong Kong-based global quantitative strategies team that they had to either relocate or leave the firm, the people told the FT. Some researchers relocated to Singapore or Miami while others quit, the people said. The development calls into question the status of Hong Kong’s future for quant development, with the city caught between US-China geopolitical tensions. In a response to the FT, the firm said that the relocations were not related to data security concerns. It added that the fund continued to hire quantitative researchers in both Hong Kong and Singapore. “This is Citadel’s global co-location strategy and has nothing to do with data security,” the hedge fund said.
格隆汇5月14日｜5月13日，佳能（中国）有限公司宣布推出创作视频机EOS R6 V，并同步发布EOS R6 V的套装镜头RF20-50mm F4 L IS USM PZ和多款EOS R系列附件。佳能EOS R6 V的机身建议零售价是13999元，搭配RF20-50mm F4 L IS USM PZ套机的建议零售价是21199元，预计将于2026年6月上市销售。
格隆汇5月14日｜5月13日，佳能（中国）有限公司宣布推出创作视频机EOS R6 V，并同步发布EOS R6 V的套装镜头RF20-50mm F4 L IS USM PZ和多款EOS R系列附件。佳能EOS R6 V的机身建议零售价是13999元，搭配RF20-50mm F4 L IS USM PZ套机的建议零售价是21199元，预计将于2026年6月上市销售。